TELA Bio, Inc.

Stage 2 · Advancing · week 4

As of Oct 22, 2026, TELA Bio is in Stage 2, the uptrend phase, now in week 4 (since Sep 29, 2026). It closed at $1.01, 32.2% below its 52-week high and above its 200-day average, which is falling.

$1.01

-6.48% today

$45.6M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

—

Momentum

Steady

Edge

—

Setup-score rank among Stage 2 peers: #1 of 35 in Medical Devices · #1 of 272 in Health Care

Is TELA early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 21w

S4 17w

S4 20w

S4 35w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 21w → S1 10w → S4 12w → S1 6w → S4 17w → S1 10w → S4 20w → S1 11w → S4 35w → S1 10w → S4 8w → S1 2w → S2 3w current

Total tracked: 166 weeks across 13 stage runs.

TELA among Medical Devices75th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…75	TELATELA Bio, Inc.	Stage 2 · wk 4	32	−22.3%

vs 52W High

-32.2%

$0.56 lo$1.49 hi

32.2% below 52W high, far from high

How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.

Stage Maturity

Week 4

1w13w26w

Week 4, early Stage 2

How long this stock has been in Stage 2. The sweet spot is mid-run: long enough to prove the structure holds, not so long that it's extended. Very fresh moves (weeks 1–4) often need more time to confirm.

vs 200 DMA

17.3%

200 DMA: $0.86 · sloping down

Long-term trend anchor. When the stock and the S&P 500 are both above their 200-day averages, the backdrop supports continuation.

Rel Volume

0.37x

vs 50-day avg

Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-22.3%

+46.2%

+62.4%

YTD

-11.4%

-33.1%

Scan Membership

Breakout Watch

Latest: 2023-07-20

4 appearances in last 60 days. First seen: 2020-09-29.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S2

Wk 4 · Vol 0.37x

2026-10-21S2

Wk 4 · Vol 0.20x

2026-10-20S2

Wk 4 · Vol 0.68x

2026-10-19S2

Wk 3 · Vol 0.61x

2026-10-16S2

Wk 3 · Vol 0.65x

2026-10-15S2

Wk 3 · Vol 1.07x

2026-10-14S2

Wk 3 · Vol 0.41x

2026-10-13S2

Wk 3 · Vol 0.23x

2026-10-12S2

Wk 2 · Vol 0.36x

2026-10-09S2

Wk 2 · Vol 0.42x

2026-10-08S2

Wk 2 · Vol 0.53x

2026-10-07S2

Wk 2 · Vol 0.65x

Moving averages & range

50 DMA

$0.97

200 DMA

$0.86

52W High

$1.49

52W Low

$0.56

5D Low

$0.97

Resistance levels (recent highs)

20d High

$1.26

60d High

$1.41

120d High

$1.41

250d High

$1.48

Next resistance

+24.8%

to 20d High

Dividend Yield

0.00%

P/B -2.9

TELA Bio: quick answers

What stage is TELA Bio in?

As of Oct 22, 2026, TELA Bio (TELA) is in Stage 2, the uptrend phase. It entered Stage 2 on Sep 29, 2026 and is in week 4. What the four stages mean

Is TELA Bio in an uptrend?

Yes. TELA Bio is in a Stage 2 uptrend. It trades 17.3% above its 200-day average, which is falling.

How far is TELA Bio from its 52-week high?

TELA Bio closed at $1.01 on Oct 22, 2026, 32.2% below its 52-week high of $1.49. Its 52-week low is $0.56.

How has TELA Bio performed over the past year?

As of Oct 22, 2026, TELA Bio is down 33.1% over the past year and down 11.4% so far in 2026.

Which sector and industry is TELA Bio in?

TELA Bio is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.